Mydriaticum (Tropicamide)

Tropicamide, the active ingredient in Mydriaticum, is an anticholinergic (muscarinic antagonist) presented as an ophthalmic solution for ocular use. It produces rapid pupil dilation and temporary paralysis of the eye’s focusing muscle, facilitating detailed eye examinations and certain diagnostic procedures.

GNH USA supplies Mydriaticum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mydriaticum acts on the muscarinic receptors of the iris and ciliary body to produce pupil dilation and cycloplegia. It is employed in several ophthalmic settings: - Ophthalmic examination: provides pupil dilation for better visualization of intra‑ocular structures. - Diagnostic procedures: induces cycloplegia to temporarily paralyze accommodation, aiding accurate refraction measurements. - Pre‑surgical assessment: facilitates intra‑ocular measurements and laser procedures by maintaining a stable, dilated pupil.

Tropicamide may cause a range of ocular and systemic reactions.

Common Side Effects: - Blurred vision: temporary loss of visual clarity due to pupil dilation. - Photophobia: increased sensitivity to light. - Ocular discomfort or stinging upon instillation. - Transient rise in intra‑ocular pressure. - Mild headache. - Conjunctival redness.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden, painful increase in intra‑ocular pressure. - Severe allergic reaction: swelling, rash, or urticaria. - Corneal ulceration or keratitis. - Persistent mydriasis lasting beyond the expected duration. - Systemic anticholinergic toxicity: dry mouth, tachycardia, confusion. - Vision loss if complications are not promptly managed.

Before using Mydriaticum, consider the following safety measures: - Assess intra‑ocular pressure: avoid in patients with narrow‑angle glaucoma. - Check for hypersensitivity: discontinue if allergic signs appear. - Use with caution in children: pediatric dosing requires specialist oversight. - Review concomitant anticholinergic drugs: risk of additive systemic effects. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Tropicamide can interact with several ocular and systemic agents.

Major Interactions (Avoid): - Systemic anticholinergics: additive anticholinergic burden may cause systemic toxicity. - Adrenergic agents (e.g., phenylephrine): may exacerbate intra‑ocular pressure elevation. - Monoamine oxidase inhibitors: potential enhancement of ocular effects.

Moderate Interactions (Monitor Closely): - Topical anesthetics: may alter corneal absorption of Tropicamide. - Other cycloplegic agents: additive cycloplegia can prolong visual impairment. - Beta‑blocker eye drops: possible fluctuations in intra‑ocular pressure requiring monitoring.